Related Experiment Video
Updated: Apr 18, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
A Bayesian three-parameter logistic model for early- and late-onset DLTs in oncology Phase I studies
Wei Zheng1, Yang Zhao1, Yuefeng Lu1
1a Sanofi Biostatistics, Sanofi-Aventis US LLC , Cambridge , Massachusetts , USA.
Abstract:
We introduce a three-parameter logistic model to analyze the dose limiting toxicity (DLT) as a time-to-event endpoint in oncology Phase I trials. In the proposed model, patients are allowed to stay on trial without the constraint of a maximum follow-up time. Our model accommodates late-onset DLT as well as early-onset DLT, by both of which the dose recommendation is informed. A Bayesian approach is used to incorporate prior knowledge of the test treatment into dose recommendation. Simulation examples show that our proposed model has good operating characteristics in assessing the maximum tolerated dose (MTD).
More Related Videos
Related Concept Videos
Dose Response Curve: Conventional Versus Nonmonotonic
Pharmacodynamic Models: Logarithmic Concentration–Effect Model
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

